Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | SPRY ARS Pharmaceuticals, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $4.22 -2.1% | $16.02 -1.8% |
| StockIQ Score | 41D Weak Risk: High | 42D Weak Risk: Medium |
| Technical | 32F | 36F |
| Fundamental | 30F | 35F |
| Growth | 26F | 50C- |
| Fair Value | 50C- | 38F |
| News | 74B | 50C- |
| Quality | 58C | 50C- |
| Risk | 40D | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
ARS Pharmaceuticals (SPRY) scores slightly higher in valuation (50 vs. 38), suggesting its stock may be seen as more attractively priced based on this metric. However, Ascentage Pharma (AAPG) leads in growth (50 vs. 26) and fundamental health (35 vs. 30), indicating stronger potential for expansion and financial stability. Both carry a "WEAK" rating, but AAPG’s technical score (36 vs. 32) also edges out SPRY.
